Dosage forms containing apomorphine for ameliorating male erectile dysfunction
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 13, 2001
Grant Date -
N/A
app pub date -
Nov 15, 1999
filing date -
Apr 22, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms so as to maintain a plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully